Dr Reddy's Laboratories Ltd
SWB:RDDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dr Reddy's Laboratories Ltd
SWB:RDDA
|
IN |
|
N
|
Nichirei Corp
OTC:NCHEY
|
JP |
|
Crocs Inc
NASDAQ:CROX
|
US |
|
J
|
Julius Baer Gruppe AG
OTC:JBAXY
|
CH |
|
Foresight Group Holdings Ltd
LSE:FSG
|
UK |
|
U
|
Universal Robina Corp
XPHS:URC
|
PH |
|
I
|
Ion Exchange (India) Ltd
NSE:IONEXCHANG
|
IN |
|
Rakus Co Ltd
TSE:3923
|
JP |
|
Sega Sammy Holdings Inc
TSE:6460
|
JP |
Wall St Price Targets
RDDA Price Targets Summary
Dr Reddy's Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for RDDA is 12.19 EUR with a low forecast of 9.37 EUR and a high forecast of 16.39 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RDDA's stock price target?
Price Target
12.19
EUR
According to Wall Street analysts, the average 1-year price target for RDDA is 12.19 EUR with a low forecast of 9.37 EUR and a high forecast of 16.39 EUR.
What is the Revenue forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 5 years is 6%.
What is the Net Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 4 years is 2%.
